New
HealthMore in Health→
MRI tumor index may help predict breast cancer drug response
Key Takeaways
- PolyU researchers developed the MRI-derived Tumour Heterogeneity Index using DCE-MRI radiomics.
- In the study, high-THI patients had an estimated pathological complete response rate of 56.1% when MK2206 was added to preoperative chemotherapy.
- The approach remains research and requires further validation before broad clinical use.
DE
DT Editorial Team··via medicalxpress.com